Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Mraz

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|November 6, 2020
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell MalignanciesLaura Ondrisova, Marek Mraz
Leukemia & Lymphoma|October 22, 2019
The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignanciesDaniel Filip, Marek Mraz
Haematologica|June 3, 2020
The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapyGabriela Pavlasova, Marek Mraz
European Journal of Haematology|August 2, 2014
B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cellsVaclav Seda, Marek Mraz
RNA Biology|October 23, 2020
LncRNAs in adaptive immunity: role in physiological and pathological conditionsPedro Faria Zeni, Marek Mraz
Leukemia & Lymphoma|April 20, 2013
MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemiaMarek Mraz, Thomas J Kipps
Cancers|July 9, 2022
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug TestingEva Hoferkova, Sona Kadakova, Marek Mraz
Seminars in Oncology|October 27, 2018
New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAsJan Devan, Andrea Janikova, Marek Mraz
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 12, 2007
MicroRNA biogenesis, functionality and cancer relevanceBranislav Kusenda, Marek Mraz, Jiri Mayer, et al.
FEBS Letters|November 13, 2024
FoxO1 signaling in B cell malignancies and its therapeutic targetingKrystof Hlavac, Petra Pavelkova, Laura Ondrisova, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|November 6, 2020
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell MalignanciesLaura Ondrisova, Marek Mraz
Leukemia & Lymphoma|October 22, 2019
The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignanciesDaniel Filip, Marek Mraz
Haematologica|June 3, 2020
The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapyGabriela Pavlasova, Marek Mraz
European Journal of Haematology|August 2, 2014
B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cellsVaclav Seda, Marek Mraz
RNA Biology|October 23, 2020
LncRNAs in adaptive immunity: role in physiological and pathological conditionsPedro Faria Zeni, Marek Mraz
Leukemia & Lymphoma|April 20, 2013
MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemiaMarek Mraz, Thomas J Kipps
Cancers|July 9, 2022
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug TestingEva Hoferkova, Sona Kadakova, Marek Mraz
Seminars in Oncology|October 27, 2018
New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAsJan Devan, Andrea Janikova, Marek Mraz
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 12, 2007
MicroRNA biogenesis, functionality and cancer relevanceBranislav Kusenda, Marek Mraz, Jiri Mayer, et al.
FEBS Letters|November 13, 2024
FoxO1 signaling in B cell malignancies and its therapeutic targetingKrystof Hlavac, Petra Pavelkova, Laura Ondrisova, et al.
Pageof 5